LuckyWinner
評論了
已翻譯
7
4
LuckyWinner
評論了
$Biodexa Pharmaceuticals(BDRX.US$ Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed ERapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6...
Benzinga· just
Benzinga· just
4
6
LuckyWinner
評論了
$Esperion Therapeutics(ESPR.US$ 希望我們能打破 3.03?然後我們就可以拍下一級!
已翻譯
2
LuckyWinner
評論了
$Regulus Therapeutics(RGLS.US$ If can break 3.30? Will be looking for 3.40, 3.56 and 3.69?
2
LuckyWinner
評論了
已翻譯
1
4
LuckyWinner
評論了
已翻譯
3
8
LuckyWinner : 在 169-170 年左右整合,現在隨時突破
LuckyWinner : 這裡來了!